Environment defines crystal formation.
BioOrbit engineers optimal crystallisation conditions through scalable microgravity.
Structure. Stability. Performance.
A proprietary crystallisation platform from discovery to production.
Designed for dual-environment operation, enabling scalable crystal production on Earth and in orbit.
Built to support every stage of the crystallisation development pathway
BOX-T
Designed and built for research
- used to validate crystallisation in microgravity
BOX-S
Unlocks pre/clinical access
- used for development through preclinical and clinical
BOX-R
Unlocks mass manufacture
- used for large scale production
A clear path from molecule to scalable crystallisation
The process:
- Assess feasibility
Determine crystallisation potential
Stage 01
- Crystallise on Earth
Establish baseline crystal forms
Stage 02
- Crystallise in microgravity
Unlock improved crystal structures
Stage 03
- Scale for development
Enable preclinical and clinical supply
Stage 04
Take biologics beyond Earth’s limits